New pill could curb binge eating episodes
NCT ID NCT05118906
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested a new drug called BP1.4979 in 67 women with moderate to severe binge eating disorder. Participants took either the drug or a placebo for a set period. Researchers measured how many binge eating episodes and days per week occurred, along with quality of life. The goal is to see if the drug can safely reduce binge eating.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BP1.4979 (a drug taken as tablets)
What this could lead to
If successful, this could point toward a new medication to help control binge eating episodes in people with binge eating disorder.
What could go wrong
This is a small, early-phase pilot study with only 67 women, so results may not apply to everyone. The drug may not work better than placebo, and side effects are still being evaluated.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BINGE EATING DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nutrition Department, La Pitié Salpêtrière Hospital
Paris, 75013, France